2014年8月,ACC/AHA联合发布了题目为「接受非心脏手术患者围手术期心血管评估与治疗指南」的临床指南。近日,Todd博士重点提取了围手术期间β受体阻滞剂的治疗管理,并进行讨论,旨在为已经或具有发生心血管疾病风险的患者欲行非心脏手术时提供围手术期间β受体阻滞剂的用药指导。全文发表在JAMA杂志上。主要意见:1若长期使用β受体阻滞剂的慢性疾病患者需要接受手术治疗,应继续使用β受体阻滞剂(Ⅰ类;证据级别 In August 2014, ACC / AHA jointly released a clinical guide entitled “Perioperative Cardiovascular Evaluation and Treatment Guidelines for Patients Undergoing Noncardiac Surgery.” Recently, Dr. Todd focused on the management and management of β blockers during perioperative interventions and discussions to provide perioperative β receptors for noncardiac surgery in patients who already have or have a cardiovascular risk Blockers medication guidance. Full text published in JAMA magazine. Key Opinion: 1 If chronic disease patients who have long been on beta blockers need surgery, beta blockers should be continued (Class I; level of evidence